Funder
Swiss National Science Foundation | nccr – on the move
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre
Kidney Cancer Association
Kidney Cancer Research Network of Canada
Ontario Research Foundation
U.S. Department of Health & Human Services | National Institutes of Health
National Science Foundation
Gouvernement du Canada | Canadian Institutes of Health Research
Canada Research Chairs
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Physiology (medical),Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference69 articles.
1. Chen, M. & Huang, J. The expanded role of fatty acid metabolism in cancer: new aspects and targets. Precis. Clin. Med 2, 183–191 (2019).
2. Chen, R. R. et al. Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells. Commun. Biol 2, 281 (2019).
3. Imoto, M. Chemistry and biology for the small molecules targeting characteristics of cancer cells. Biosci. Biotechnol. Biochem. 83, 1–10 (2018).
4. Menendez, J. A. & Lupu, R. Fatty acid synthase (FASN) as a therapeutic target in breast cancer. Expert Opin. Ther. Targets 21, 1001–1016 (2017).
5. Garber, K. Cancer anabolic metabolism inhibitors move into clinic. Nat. Biotechnol. 34, 794–795 (2016).
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献